We are live on
!
Find out more
FPC
Falcon Point Capital Portfolio holdings
AUM
$11.9M
1-Year Est. Return
55.76%
This Fund
S&P 500
This Quarter
Est. Return
+16.28%
1 Year Est. Return
+55.76%
3 Year Est. Return
+118.89%
5 Year Est. Return
+197.9%
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$16.3M
(+9.7%)
Cap. Flow
-$7.35M
Cap. Flow
% of AUM
-4.01%
Top 10 Holdings %
Top 10 Hldgs %
29.96%
Holding
117
New
14
Increased
35
Reduced
41
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$4.23M |
| 2 |
Merit Medical Systems
MMSI
|
+$3.47M |
| 3 |
ICF International
ICFI
|
+$2.11M |
| 4 |
Ligand Pharmaceuticals
LGND
|
+$808K |
| 5 |
Upland Software
UPLD
|
+$723K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Omnicell
OMCL
|
+$3.17M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
+$2.7M |
| 3 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
+$2.48M |
| 4 |
Myriad Genetics
MYGN
|
+$2.09M |
| 5 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$1.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.8% |
| 2 | Technology | 18.55% |
| 3 | Healthcare | 15.74% |
| 4 | Consumer Discretionary | 11.45% |
| 5 | Financials | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNDT
1
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $6.96M | 3.79% |
414,285
-22,860
| -5% | -$385K |
|
2
Caesars Entertainment
CZR
$6.08B
| $6.23M | 3.39% |
133,405
-7,239
| -5% | -$330K |
|
3
FTAI Aviation
FTAI
$21.3B
| $5.92M | 3.23% |
405,535
-12,263
| -3% | -$164K |
|
|
PFPT
4
DELISTED
Proofpoint, Inc.
PFPT
| $5.9M | 3.21% |
48,561
-4,712
| -9% | -$517K |
|
|
CSII
5
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.56M | 3.03% |
143,828
+124,676
| +651% | +$4.23M |
|
6
Jack in the Box
JACK
$286M
| $5.5M | 3% |
67,881
-4,281
| -6% | -$342K |
|
7
FIVE9
FIVN
$1.96B
| $4.98M | 2.71% |
94,275
-3,297
| -3% | -$168K |
|
|
AGS
8
DELISTED
PlayAGS
AGS
| $4.82M | 2.63% |
201,458
+23,669
| +13% | +$584K |
|
|
WAGE
9
DELISTED
WageWorks, Inc.
WAGE
| $4.6M | 2.51% |
121,784
+21,611
| +22% | +$705K |
|
10
Strategic Education
STRA
$1.73B
| $4.51M | 2.46% |
34,387
-3,951
| -10% | -$481K |
|
11
NeoGenomics
NEO
$1.9B
| $4.5M | 2.45% |
219,992
-88,434
| -29% | -$1.54M |
|
12
Integra LifeSciences
IART
$1.5B
| $4.5M | 2.45% |
80,729
-3,526
| -4% | -$180K |
|
|
WIFI
13
DELISTED
Boingo Wireless, Inc.
WIFI
| $4M | 2.18% |
171,953
+18,279
| +12% | +$416K |
|
|
CSOD
14
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $3.96M | 2.16% |
72,321
-3,274
| -4% | -$181K |
|
15
MasTec
MTZ
$26B
| $3.84M | 2.09% |
79,884
-3,455
| -4% | -$155K |
|
|
16
Ligand Pharmaceuticals
LGND
$6.08B
| $3.83M | 2.09% |
48,900
+10,667
| +28% | +$808K |
|
|
SPNE
17
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $3.83M | 2.09% |
253,858
+32,226
| +15% | +$498K |
|
|
18
ICF International
ICFI
$1.43B
| $3.78M | 2.06% |
49,689
+29,877
| +151% | +$2.11M |
|
|
19
Merit Medical Systems
MMSI
$4.41B
| $3.78M | 2.06% |
+61,087
| New | +$3.47M |
|
20
Brink's
BCO
$4.95B
| $3.77M | 2.06% |
50,019
+153
| +0.3% | +$11.4K |
|
|
VG
21
DELISTED
Vonage Holdings Corporation
VG
| $3.54M | 1.93% |
352,483
+46,653
| +15% | +$448K |
|
|
BEAT
22
DELISTED
BioTelemetry, Inc.
BEAT
| $3.48M | 1.9% |
55,619
-28,099
| -34% | -$1.93M |
|
|
PRFT
23
DELISTED
Perficient Inc
PRFT
| $3.41M | 1.86% |
124,354
-28,524
| -19% | -$751K |
|
24
Box
BOX
$4.22B
| $3.39M | 1.84% |
175,350
+24,914
| +17% | +$516K |
|
|
MPT
25
Medical Properties Trust
MPT
$2.84B
| $3.25M | 1.77% |
175,398
-76,867
| -30% | -$1.37M |
|
Similar funds
GFWEX
SAM
VAIA
HAM
AIDCT
RC
NCM
GBA
Falcon Point Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Falcon Point Capital held 117 positions worth $184M, up 9.7% from $167M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Falcon Point Capital withdrew a net $7.35M in Q1 2019, closing 11 positions and reducing 41 holdings. Its most notable exit was Supernus Pharmaceuticals, an estimated $2.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Falcon Point Capital opened a new position in Merit Medical Systems worth $3.78M.
- Falcon Point Capital's largest Q1 2019 buy was Merit Medical Systems: 61,087 shares worth $3.78M.
- Falcon Point Capital added most to Cardiovascular Systems, Inc. in Q1 2019, an estimated $4.23M increase.
- Falcon Point Capital's biggest Q1 2019 reduction was Omnicell, cutting an estimated $3.17M.
- Falcon Point Capital fully exited Supernus Pharmaceuticals in Q1 2019, selling an estimated $2.7M.
- Falcon Point Capital's ten largest holdings make up 30% of its $184M portfolio in Q1 2019.
- Falcon Point Capital opened 14 new positions and closed 11 in Q1 2019.
- Falcon Point Capital's portfolio value rose 9.7% quarter-over-quarter to $184M.
Based on Falcon Point Capital's 13F filing for Q1 2019, filed 8 May 2019.